237 related articles for article (PubMed ID: 20181897)
1. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Cisneros JM; Peña C; Almela M; Almirante B; Grill F; Colomina J; Molinos S; Oliver A; Fernández-Mazarrasa C; Navarro G; Coloma A; López-Cerero L; Pascual A
J Clin Microbiol; 2010 May; 48(5):1726-31. PubMed ID: 20181897
[TBL] [Abstract][Full Text] [Related]
2. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A;
Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215
[TBL] [Abstract][Full Text] [Related]
3. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
[TBL] [Abstract][Full Text] [Related]
4. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections.
Superti SV; Augusti G; Zavascki AP
Rev Inst Med Trop Sao Paulo; 2009; 51(4):211-6. PubMed ID: 19739001
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Perea EJ; Pérez-Cano R; Hernández JR; Pascual A
Clin Infect Dis; 2006 Jan; 42(1):37-45. PubMed ID: 16323089
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli.
Wu UI; Yang CS; Chen WC; Chen YC; Chang SC
J Microbiol Immunol Infect; 2010 Aug; 43(4):310-6. PubMed ID: 20688291
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia.
Park YS; Bae IK; Kim J; Jeong SH; Hwang SS; Seo YH; Cho YK; Lee K; Kim JM
Yonsei Med J; 2014 Mar; 55(2):467-75. PubMed ID: 24532519
[TBL] [Abstract][Full Text] [Related]
11. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?
Goulenok T; Ferroni A; Bille E; Lécuyer H; Join-Lambert O; Descamps P; Nassif X; Zahar JR
J Hosp Infect; 2013 Aug; 84(4):294-9. PubMed ID: 23846237
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
Scheuerman O; Schechner V; Carmeli Y; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Molina J; Hernández-Torres A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Navarro-San Francisco C; Bonomo RA; Paterson DL; Pascual A; Rodríguez-Baño J;
Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing
Liang T; Xu C; Cheng Q; Tang Y; Zeng H; Li X
Microb Drug Resist; 2021 Jun; 27(6):800-808. PubMed ID: 33232654
[No Abstract] [Full Text] [Related]
15. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Park SY; Kang CI; Joo EJ; Ha YE; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Microb Drug Resist; 2012 Oct; 18(5):518-24. PubMed ID: 22742454
[TBL] [Abstract][Full Text] [Related]
17. Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study.
Díaz MA; Hernández-Bello JR; Rodríguez-Baño J; Martínez-Martínez L; Calvo J; Blanco J; Pascual A;
J Clin Microbiol; 2010 Aug; 48(8):2840-5. PubMed ID: 20519460
[TBL] [Abstract][Full Text] [Related]
18. Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU.
Liu M; Li M; Wu L; Song Q; Zhao D; Chen Z; Kang M; Xie Y
Medicine (Baltimore); 2018 Sep; 97(38):e12445. PubMed ID: 30235729
[TBL] [Abstract][Full Text] [Related]
19. An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome.
Nasa P; Juneja D; Singh O; Dang R; Singh A
Eur J Intern Med; 2012 Mar; 23(2):192-5. PubMed ID: 22284253
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
